Skip to main content
ArticleOPEN ACCESS

Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

Scientific reports
DOI: 10.1038/srep46645
4Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Coni, S., Mancuso, A. B., Di Magno, L., Sdruscia, G., Manni, S., Serrao, S. M., … Canettieri, G. (2017, April 21). Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Scientific Reports. NLM (Medline). https://doi.org/10.1038/srep46645

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free